FOLH1 and metastatic neoplasm: These findings not only agree with results of prospective studies that defined the diagnostic yield of PSMA-PET imaging but also highlight the potential for PSMA-PET imaging to facilitate the earlier and potentially indefinite use of systemic therapy in patients identified to have otherwise occult metastatic disease by conventional imaging.32